Literature DB >> 10753888

Plakoglobin regulates the expression of the anti-apoptotic protein BCL-2.

S Hakimelahi1, H R Parker, A J Gilchrist, M Barry, Z Li, R C Bleackley, M Pasdar.   

Abstract

Plakoglobin is a cytoplasmic protein and a homologue of beta-catenin and Armadillo of Drosophila with similar adhesive and signaling functions. These proteins interact with cadherins to mediate cell-cell adhesion and associate with transcription factors to induce changes in the expression of genes involved in cell fate determination and proliferation. Unlike the relatively well characterized role of beta-catenin in cell proliferation via activation of c-MYC and cyclin D1 gene expression, the signaling function of plakoglobin in regulation of cell growth is undefined. Here, we show that high levels of plakoglobin expression in plakoglobin-deficient human SCC9 cells leads to uncontrolled growth and foci formation. Concurrent with the change in growth characteristics we observe a pronounced inhibition of apoptosis. This correlates with an induction of expression of BCL-2, a prototypic member of apoptosis-regulating proteins. The BCL-2 expression coincides with decreased proteolytic processing and activation of caspase-3, an executor of programmed cell death. Our data suggest that the growth regulatory function of plakoglobin is independent of its role in mediating cell-cell adhesion. These observations clearly implicate plakoglobin in pathways regulating cell growth and provide initial evidence of its role as a pivotal molecular link between pathways regulating cell adherence and cell death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753888     DOI: 10.1074/jbc.275.15.10905

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Plakoglobin regulates cell motility through Rho- and fibronectin-dependent Src signaling.

Authors:  Viktor Todorović; Bhushan V Desai; Melanie J Schroeder Patterson; Evangeline V Amargo; Adi D Dubash; Taofei Yin; Jonathan C R Jones; Kathleen J Green
Journal:  J Cell Sci       Date:  2010-09-28       Impact factor: 5.285

2.  The Barrier Molecules Junction Plakoglobin, Filaggrin, and Dystonin Play Roles in Melanoma Growth and Angiogenesis.

Authors:  Katie M Leick; Anthony B Rodriguez; Marit M Melssen; Mouadh Benamar; Robin S Lindsay; Rebeka Eki; Kang-Ping Du; Mahmut Parlak; Tarek Abbas; Victor H Engelhard; Craig L Slingluff
Journal:  Ann Surg       Date:  2019-10       Impact factor: 12.969

3.  Desmoglein-3/γ-catenin and E-cadherin/ß-catenin differential expression in oral leukoplakia and squamous cell carcinoma.

Authors:  Marianthi Kyrodimou; Dimitrios Andreadis; Angeliki Drougou; Elsa P Amanatiadou; Lefteris Angelis; Calypso Barbatis; Apostolos Epivatianos; Ioannis S Vizirianakis
Journal:  Clin Oral Investig       Date:  2013-02-22       Impact factor: 3.573

4.  Cancer: Staying together on the road to metastasis.

Authors:  Alessia Bottos; Nancy E Hynes
Journal:  Nature       Date:  2014-10-16       Impact factor: 49.962

5.  γ-Catenin is an independent prognostic marker in early stage colorectal cancer.

Authors:  Jutta Maria Nagel; Lydia Kriegl; David Horst; Jutta Engel; Shiva Gautam; Christos S Mantzoros; Thomas Kirchner; Burkhard Göke; Frank Thomas Kolligs
Journal:  Int J Colorectal Dis       Date:  2010-08-25       Impact factor: 2.571

6.  γ-Catenin acts as a tumor suppressor through context-dependent mechanisms in colorectal cancer.

Authors:  Jutta Maria Nagel; Harald Lahm; Andrea Ofner; Burkhard Göke; Frank Thomas Kolligs
Journal:  Int J Colorectal Dis       Date:  2017-07-06       Impact factor: 2.571

Review 7.  Desmosomes: new perpetrators in tumour suppression.

Authors:  Rachel L Dusek; Laura D Attardi
Journal:  Nat Rev Cancer       Date:  2011-05       Impact factor: 60.716

Review 8.  Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Mark M Awad; Hugh Calkins; Daniel P Judge
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-04-01

9.  A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy.

Authors:  Angeliki Asimaki; Petros Syrris; Thomas Wichter; Paul Matthias; Jeffrey E Saffitz; William J McKenna
Journal:  Am J Hum Genet       Date:  2007-09-28       Impact factor: 11.025

10.  Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

Authors:  Nicola Aceto; Aditya Bardia; David T Miyamoto; Maria C Donaldson; Ben S Wittner; Joel A Spencer; Min Yu; Adam Pely; Amanda Engstrom; Huili Zhu; Brian W Brannigan; Ravi Kapur; Shannon L Stott; Toshi Shioda; Sridhar Ramaswamy; David T Ting; Charles P Lin; Mehmet Toner; Daniel A Haber; Shyamala Maheswaran
Journal:  Cell       Date:  2014-08-28       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.